新冠病毒的德尔塔+变种可能是目前世界各地的德尔塔变种之中更具传染性的变种,正开始向新地区蔓延。
韩国官员表示,他们已经确认了两例德尔塔+病例,一例是40多岁的男性,“最近没有旅行史”,另一例最近从美国回国。据报道,第二例确诊病例注射了两剂阿斯利康的新冠病毒疫苗。
世界卫生组织(World Health Organization)将德尔塔+列为“须关切变种”,6月份在英国首次发现。此后,美国、印度、中国、俄罗斯和日本等多个国家也发现了这种病毒。
目前还不确定人们应该如何看待这种变种。有关这种变体的数据仍然在初步统计中的,这使一些卫生官员怀疑,将其从“待观察变种”升级为“须关切变种”是否为时过早。
据《印度斯坦时报》报道,截至7月23日,印度共有70例德尔塔+变种病例。在英国至少发现了39个病例。
德尔塔+变种病毒尚未证明其比德尔塔变种或其他变种病毒更有传染性。到目前为止,德尔塔+病毒变种的传播主要发生在年轻人之中。虽然这些数据还处于初步研究阶段,但似乎接种疫苗的人体内的抗体对这种变种仍然有效。不过,专家警告说,这些发现可能与真实情况有所出入,因为实验样本量仍然很小。
新冠病毒依然肆虐,政府官员们正在密切关注几种病毒变种,德尔塔+只是其中之一。(财富中文网)
编译:於欣
新冠病毒的德尔塔+变种可能是目前世界各地的德尔塔变种之中更具传染性的变种,正开始向新地区蔓延。
韩国官员表示,他们已经确认了两例德尔塔+病例,一例是40多岁的男性,“最近没有旅行史”,另一例最近从美国回国。据报道,第二例确诊病例注射了两剂阿斯利康的新冠病毒疫苗。
世界卫生组织(World Health Organization)将德尔塔+列为“须关切变种”,6月份在英国首次发现。此后,美国、印度、中国、俄罗斯和日本等多个国家也发现了这种病毒。
目前还不确定人们应该如何看待这种变种。有关这种变体的数据仍然在初步统计中的,这使一些卫生官员怀疑,将其从“待观察变种”升级为“须关切变种”是否为时过早。
据《印度斯坦时报》报道,截至7月23日,印度共有70例德尔塔+变种病例。在英国至少发现了39个病例。
德尔塔+变种病毒尚未证明其比德尔塔变种或其他变种病毒更有传染性。到目前为止,德尔塔+病毒变种的传播主要发生在年轻人之中。虽然这些数据还处于初步研究阶段,但似乎接种疫苗的人体内的抗体对这种变种仍然有效。不过,专家警告说,这些发现可能与真实情况有所出入,因为实验样本量仍然很小。
新冠病毒依然肆虐,政府官员们正在密切关注几种病毒变种,德尔塔+只是其中之一。(财富中文网)
编译:於欣
The Delta Plus variant of COVID-19, which could be an even more contagious mutation of the Delta variant that’s currently infecting people around the world, is beginning to spread to new regions.
Officials in South Korea say they’ve confirmed two cases of Delta Plus, one in a man in his forties with “no recent travel records” and the second from a person who recently returned from the U.S. The second confirmed case had reportedly received both doses of AstraZeneca’s coronavirus vaccine.
Delta Plus, which the World Health Organization lists as a “variant of concern,” was first detected in the U.K. in June. It has since been found in several other countries, including the U.S., India, China, Russia, and Japan.
It’s uncertain at this point how concerned people should be about this variant. Data about the variant is still preliminary, which has led some health officials to wonder if the upgrade from "variant of interest" to one of concern might have been premature.
As of July 23, there were 70 cases of the Delta Plus variant in India, according to the Hindustan Times. At least 39 have been discovered in the U.K.
Delta Plus has not yet shown that its mutations give it a contagion advantage over the Delta variant or other mutations. Infections, so far, have primarily been in younger people. And while the data is still preliminary, it seems that antibodies in vaccinated people are still effective against this variant. Experts warn those findings could shift, though, since the sample size is still very small.
Delta Plus is just one of several variants officials are keeping their eye on as COVID-19 continues to spread.